Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$11.21 USD
+0.04 (0.36%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $11.19 -0.02 (-0.18%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Dynavax Technologies Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -6.39 | 293.16 | 76.71 | -75.24 | -152.60 |
Depreciation/Amortization & Depletion | -9.28 | 2.49 | 7.48 | 9.87 | 20.07 |
Net Change from Assets/Liabilities | 61.21 | -298.42 | 172.22 | -32.91 | -33.67 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 55.03 | 65.49 | 79.11 | 6.03 | 44.95 |
Net Cash From Operating Activities | 100.56 | 62.72 | 335.53 | -92.25 | -121.25 |
Property & Equipment | -3.10 | -6.14 | -8.48 | 2.78 | -22.40 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | -7.00 | -7.00 |
Investments | -150.82 | -309.86 | 22.70 | -22.31 | -13.38 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -153.93 | -316.00 | 14.23 | -26.53 | -42.78 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.54 | 19.53 | 46.81 | 109.21 | 80.10 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -190.19 | 0.00 | 74.25 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 219.82 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.15 | 0.00 | -20.66 | 0.29 | 0.00 |
Net Cash from Financing Activities | 1.39 | 19.53 | 55.78 | 109.50 | 154.35 |
Effect of Exchange Rate Changes | 0.32 | -0.44 | -1.43 | 1.49 | -0.18 |
Net Change In Cash & Equivalents | -51.66 | -234.20 | 404.10 | -7.79 | -9.87 |
Cash at Beginning of Period | 202.21 | 436.41 | 32.31 | 40.10 | 49.97 |
Cash at End of Period | 150.56 | 202.21 | 436.41 | 32.31 | 40.10 |
Diluted Net EPS | -0.05 | 1.97 | 0.57 | -0.78 | -2.16 |
Fiscal Year End for Dynavax Technologies Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -6.39 | -6.61 | -20.90 | -24.33 |
Depreciation/Amortization & Depletion | NA | -9.28 | -6.00 | -3.82 | -1.84 |
Net Change from Assets/Liabilities | NA | 61.21 | 54.56 | 46.92 | 29.76 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 55.03 | 44.84 | 33.47 | 24.03 |
Net Cash From Operating Activities | NA | 100.56 | 86.80 | 55.67 | 27.62 |
Property & Equipment | NA | -3.10 | -1.38 | -2.03 | -1.28 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -150.82 | -132.31 | -25.58 | -51.05 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -153.93 | -133.69 | -27.61 | -52.33 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 1.54 | 5.87 | 2.39 | 0.78 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.15 | -6.26 | -5.78 | -3.87 |
Net Cash from Financing Activities | NA | 1.39 | -0.39 | -3.38 | -3.09 |
Effect of Exchange Rate Changes | NA | 0.32 | -0.16 | 0.15 | 0.15 |
Net Change In Cash & Equivalents | NA | -51.66 | -47.43 | 24.82 | -27.65 |
Cash at Beginning of Period | NA | 202.21 | 202.21 | 202.21 | 202.21 |
Cash at End of Period | NA | 150.56 | 154.78 | 227.03 | 174.56 |
Diluted Net EPS | NA | 0.01 | 0.10 | 0.03 | -0.19 |